Effects of chronic treatment with the new ultra-long-acting β(2)-adrenoceptor agonist indacaterol alone or in combination with the β(1)-adrenoceptor blocker metoprolol on cardiac remodelling

BACKGROUND AND PURPOSE: The ability of a chronic treatment with indacaterol, a new ultra-long-acting β(2)-adrenoceptor agonist, to reverse cardiac remodelling and its effects in combination with metoprolol, a selective β(1)-adrenoceptor antagonist, were investigated on myocardial infarction in a rat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Pharmacol
Main Authors: Rinaldi, Barbara, Donniacuo, Maria, Sodano, Loredana, Gritti, Giulia, Martuscelli, Eugenio, Orlandi, Augusto, Rafaniello, Concetta, Rossi, Francesco, Calzetta, Luigino, Capuano, Annalisa, Matera, Maria Gabriella
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd 2015
Assuntos:
Research Papers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4507164/
https://ncbi.nlm.nih.gov/pubmed/25825265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13148
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados